8.22  0.09 (1.11%)		04-19 16:00
Open: 8.16 High: 8.22 Volume: 3,430,403		Pre. Close: 8.13 Low: 8.145 Market Cap: 37,534(M)

Short term
Mid term
Targets	6-month :	9.71	1-year :	10.02
Resists	First :	8.31	Second :	8.58
Pivot price	8.19
Supports	First :	7.88	Second :	6.56
MAs	MA(5) :	8.12	MA(20) :	8.25
	MA(100) :	8.31	MA(250) :	8.33
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	30	D(3) :	22.5
RSI	RSI(14): 48.9
52-week	High :	8.98	Low :	7.69

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ HLN ] has closed below upper band by 42.0%. Bollinger Bands are 37.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	8.22 - 8.25	8.25 - 8.28
Low:	8.07 - 8.1	8.1 - 8.13
Close:	8.17 - 8.21	8.21 - 8.26

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Thu, 18 Apr 2024
HSBC starts Haleon at 'buy' - ShareCast

Wed, 17 Apr 2024
Haleon (NYSE:HLN) Earns Buy Rating from Analysts at HSBC - MarketBeat

Sat, 13 Apr 2024
Sequoia Financial Advisors LLC Boosts Stock Position in Haleon plc (NYSE:HLN) - MarketBeat

Sat, 13 Apr 2024
Should Weakness in Haleon plc's (LON:HLN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Simply Wall St

Fri, 12 Apr 2024
Haleon PLC Announces Virtual AGM for Shareholders - TipRanks.com - TipRanks

Thu, 21 Mar 2024
Haleon PLC Announces Major Share Offering - TipRanks.com - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	4,570 (M)
Shares Float	6,720 (M)
Held by Insiders	4.3 (%)
Held by Institutions	8.7 (%)
Shares Short	20,810 (K)
Shares Short P.Month	14,320 (K)

EPS	0.28
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.79
Profit Margin	9.2 %
Operating Margin	19.5 %
Return on Assets (ttm)	4.2 %
Return on Equity (ttm)	6.6 %
Qtrly Rev. Growth	-0.5 %
Gross Profit (p.s.)	0
Sales Per Share	2.47
EBITDA (p.s.)	0.55
Qtrly Earnings Growth	0 %
Operating Cash Flow	2,100 (M)
Levered Free Cash Flow	1,170 (M)

PE Ratio	29.35
PEG Ratio	0
Price to Book value	4.56
Price to Sales	3.32
Price to Cash Flow	17.88

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.